Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

Chest

Volumn 121, Issue 6, 2002, Pages 1812-1817

  Martín García, Cristina ^a   Hinojosa, Miguel ^a   Berges, Pilar ^a   Camacho, Encarnación ^a   García Rodriguez, Rosa ^a   Alfaya, Teresa ^a   Iscar, Alberto ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Aspirin induced asthma; Asthma; Cyclooxygenase enzyme; Cyclooxygenase 2 inhibitors; Rofecoxib

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; CYCLOOXYGENASE 2 INHIBITOR; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROSTAGLANDIN; ROFECOXIB;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERANCE; ENZYME INHIBITION; EPIGASTRIC PAIN; FEMALE; HEARTBURN; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036283384     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.6.1812     Document Type: Article

References (28)

1. Aspirin-induced asthma: Advances in pathogenesis and management
2. Intolerance to nonste-roidal antiinflammatory drugs: Results controlled drug challenges in 98 patients
3. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation
4. Long-term prognosis of near-fatal asthma: A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma
5. The cyclooxygenase theory of aspirin-induced asthma
6. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
7. Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics
8. COX-2 inhibitors
9. Asthma guidelines and outcomes
10. Oral challenge with alternative nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents
11. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects
12. Acetaminophen anaphylaxis with aspirin and sodium salicylate sensitivity: A case report
13. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin
14. Relative safety of meloxicam in NSAID-intolerant patients
15. Nimesulida como tratamiento alternativo en pacientes con intolerancia a antiinflamatorios no esteroideos
16. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance
17. Bloqueadores de receptores COX-2: Experiencia con nimesulide
18. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1
19. NSAIDs, Cox-2 inhibitors, and the gut
20. Rofecoxib
21. Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: A randomized controlled trial
22. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
23. Rofecoxib: A review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis
24. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip; Rofecoxib Phase III Protocol 035 Study Group
25. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis: Rofecoxib/Ibuprofen Comparator Study Group
26. Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis
27. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs